The goal of this activity is to provide clinicians with the clinical tools necessary to identify and manage treatment-refractory and drug-resistant CMV in patients after solid organ transplantation (SOT). A panel of infectious diseases experts review current CMV treatment guidelines, discuss antiviral resistance testing, and provide insights for management with a new antiviral therapeutic option. An experienced patient with CMV provides important practical take-aways for clinicians to use with their own SOT patients.
Upon completion of this activity, participants should be better able to:
Professor, Department of Medicine
University of Toronto
R. Fraser Elliott Chair, Transplantation
University Health Network
Director, University of Toronto Transplant Institute
Toronto, Ontario, Canada
Professor, Medicine
Program Director, Infectious Diseases Fellowship Program
Vice Chair, Division of Infectious Diseases
Mayo Clinic
Rochester, Minnesota, United States
Director, Clinical Operations
Transplant Infectious Diseases
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Resources
Featured RMEI CE Activities
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources
